Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022 - GuruFocus.com
Submitted by Anonymous (not verified) on Wed, 06/22/2022 - 13:47
